There is convincing evidence that unsaturated fatty acids exert favourable effects on plasma cholesterol levels. However, it is not clear which type of oil has the most pronounced effect, especially not in paediatric patients. The aim was to compare two low-fat diet regimes enriched with either monounsaturated fatty acids by rapeseed oil (RO) or polyunsaturated fatty acids by sunflower oil (SO) in children affected with familial hypercholesterolaemia (FH). SUBJECTS/METHODS: Twenty-one children aged 6-18 years affected with FH were enrolled in this randomized and double-blind pilot trial. The subjects and their families were trained to adhere to a low-fat/low-cholesterol diet. All visible fats were to be replaced by either RO or SO (14-27 g/day) for 13 weeks. Dietary adherence was controlled by repeated 4-day dietary records; plasma lipids, lipoproteins and risk markers were assessed at baseline and post-intervention. Out of 21 subjects, 16 could be followed-up after 6 months. RESULTS: Both fat-modified diets resulted in significant reduction in total cholesterol concentrations of 9.4% (RO P o 0.005 vs SO Po 0.05) and low-density lipoprotein (LDL) cholesterol concentrations of 12.7% (P o 0.005) for RO and 11.3% (Po 0.05) for SO. The reduction of the LDL/high-density lipoprotein (HDL) cholesterol ratio (RO 9% vs SO 3.5%) and high-sensitivity C-reactive protein (RO 16.8% vs SO 1.7%) were not statistically significant, respectively. In most participating families, a change in eating habits could be observed. CONCLUSIONS: A fat-modified diet enriched with RO seems to have very similar effects on cholesterol levels as with SO. However, our study suggests that RO has possibly more favourable effects concerning cardiovascular risk profile. Both diets appear to be feasible and were well accepted among our subjects. Although these results are promising, larger trials will be required to validate our findings. 
INTRODUCTION
Heterozygous familial hypercholesterolaemia (FH)-an autosomal dominant inherited metabolic disorder with an incidence of approximately 1:500 in the general population-is characterized by markedly elevated levels of total plasma cholesterol (TC) and low-density lipoprotein (LDL) cholesterol typically well above the 95th percentile for age and sex. 1 This significant increase in plasma cholesterol levels is mainly caused by a mutation in the LDL receptor gene on the short arm of chromosome 19. Today, more than 1000 different mutations have been described worldwide, which result in impaired LDL re-absorption and catabolism in the cells. Furthermore, the familial defective ligand apolipoprotein B-100 (apoB) is related to FH and results in the same symptoms but is caused by a different abnormal gene. 2 Approximately 85% of affected men and 50% of affected women suffer from cardiovascular events before the age of 65 years, if not treated sufficiently. First signs of functional and morphological changes leading to atherosclerosis can already be detected in adolescents with FH but can presumably be reversed by an early reduction of cholesterol levels. In a study by Wiegman et al., 3 it was shown that the intima-media thickness (IMT) in childhood of FH patients increases as much as five times faster than in their healthy siblings. Early diagnosis and adequate therapy should therefore be started in childhood to prevent disease-related sequelae. 4, 5 There are two main strategies to reduce elevated cholesterol levels: diet and medication. Especially in childhood, it is desirable to utilize lipid-lowering dietary methods, while drugs should be applied only after failure of diet therapy as the long-term effects of drug treatment are not well known. Furthermore, an early change of diet habits in the treatment of patients is extremely cost effective and can delay the need for lipid-lowering medication to a later point in life, thereby minimizing potential side effects. 6, 7 Fatty acid composition and cholesterol content are important aspects of the diet. Most recommendations, such as the National Cholesterol Education Program and the American Academy of 1 Pediatrics, suggest a low-fat (⩽30% of total daily energy) and low-cholesterol (o 200 mg per day) diet with a significant reduction in saturated fat (o 7% of total energy), for all children aged 2 years or older. 8, 9 In the last decades several studies documented a positive effect on plasma cholesterol levels by intake of monounsaturated (MUFAs) and polyunsaturated fatty acids (PUFAs) in hypercholesterolaemic adults. [10] [11] [12] [13] [14] [15] [16] [17] [18] Therefore, there is a growing interest in their use as an alternative therapy method in young patients with heterozygous FH. Especially n-3 fatty acids could be of major importance, because of their biological effects in prevention of cardiovascular disease (CVD). 4 For this reason, we initiated a pilot study to assess the feasibility of domestic vegetable oils in a lipid-lowering diet for paediatric patients affected with FH. The goal was to examine the different effects of a fat-modified diet with rapeseed oil (RO; diet rich in MUFA) compared with sunflower oil (SO; diet rich in PUFA) on lipoprotein and apolipoprotein levels in children and adolescents affected with FH. The secondary objective was to investigate if long-term changes in dietary habits may be achieved by the support of a multi-professional team and involvement of the entire family.
SUBJECTS AND METHODS Subjects
The study was conducted between July 2007 and July 2010. Study participants were recruited from the paediatric outpatient clinic for metabolic disorders at the Vienna General Hospital. Overall, 31 out of 90 children and adolescents who underwent the pre-enrolment screening process met the following inclusion criteria (see Figure 1) . Study participants had to be aged between 6 to 18 years, show increased plasma cholesterol levels (LDL cholesterol 4130 mg/dl, TC 4200 mg/dl) and have a positive family history of premature CVD (men o55 years, women o65 years) according to the American Academy of Pediatrics criteria for the diagnosis of FH. 19 Exclusion criteria comprised of mental disability, the concomitant use of drugs, a regular consumption of soy protein because of the effect of isoflavones 20, 21 on blood lipids or an already increased intake of RO or SO. Informed consent was obtained from all participants and their parents. The study protocol was submitted to the Ethics Committee of the Medical University of Vienna for approval (no. 482/2007).
However, 10 patients dropped out during the study, because of scheduling problems or personal reasons. Six subjects were not compliant to the diet and had to be excluded from statistical analysis. Out of 31 randomized patients, data on 15 girls and 6 boys (11.1 ± 3.4 years) were available for evaluation of the intervention. Twelve of these patients had been assigned to the RO group and nine patients to the SO group. In each group, there were three male participants. Patient's characteristics are presented in Table 1 . BMI of two subjects was above the 97th or below the 3rd percentiles, according to the criteria of Kromeyer-Hauschild et al., 22 respectively. Elevated blood pressure (⩾95th percentile) 23 was detected in two 8-year-old girls and one 10-year-old boy. Thirteen of twenty-one subjects showed an additional risk factor of elevated lipoprotein(a) concentrations. Other clinical parameters were within normal ranges. None of the patients showed clinical signs of hypercholesterolaemia, such as xanthoma or arcus corneae. In six of twenty-one subjects, clinical diagnosis of FH was additionally confirmed by detection of a gene mutation (five patients showed a mutation in the LDL receptor gene, in one patient a failure in the apoB gene was detected). In the remaining 15 subjects, no known FH causing genetic defect was found.
Study design
For this study, we aimed to recruit a sample size of 30 participants with an estimated drop-out rate of 10% (that is 33 in total). As positive effects of a Effects of diet in hypercholesterolemic children L Negele et al fat-modified diet are well known and documented, 24, 25 we did not implement a control group without treatment because of ethical considerations. A randomized double-blind design was chosen. A computer-generated centralized randomization, balanced by age with the 'biased coin' method, assigned the subjects to the study groups. The study was divided into three sections over a period of 10 months.
Phase 1 (Pretests). All patients underwent a comprehensive medical anamnesis and examination, nutrition survey and psychological examination within 2 weeks. The medical examination included measurement of weight, height, BMI, body composition by bioelectrical impedance analysis as well as of IMT and blood pressure. Furthermore, a clinical examination for xanthomas and arcus corneae was conducted. Venous fasting blood samples (including genetic testing) for plasma composition analysis of lipoproteins, apolipoproteins and risk markers for CVD as well as fatty acid composition was drawn. Medical anamnesis and a family history concerning high cholesterol and cardiovascular events in close relatives were recorded.
The subjects and their parents were intensively instructed by a dietician on how to keep a detailed dietary history. In addition, physical activity was to be recorded. Parents of participants below 12 years of age were asked to help their children. A 7-day dietary record was conducted for evaluation of eating habits and nutrient intake as well as quantitative fatty acid intake at baseline. The evaluation of the diet records carried out with the computerbased nutrition programme EBISpro based on the German Nutrient Data Base Version II.3.1.
Phase 2 (Intervention).
During the intervention period of 3 months, each subject was asked to replace as many visible fat sources as possible by either RO or SO for preparation of meals (for example, for baking, frying and other means of meal preparation, in salads, and as a spread) and generally reduce cholesterol intake. The families of the enroled subjects were provided with the appropriate oil, without knowing the special type. Amounts of the study oil intakes were about 15-27 g calculated by the energy requirement of the D-A-CH (Germany (D), Austria (A) and Switzerland (CH)) reverence values. 26 Every 2 weeks there was a check-up in which parents received the new oil in coloured tubes and giving back used tubes. The residue of oil was measured and thus the actual oil revenue calculated. A regular intake of more than 70% of the total amount of the provided oil was considered as compliant. At these visits a medical examination, a psychological interview and a nutritional consultation were performed. If a patient did not show up, an alternative appointment was actively sought by the study team, thereby increasing adherence. Subjects were asked to report any adverse event. Detailed instructions to improve nutrition habits were personally given to the patients and their parents from an experienced dietician. Children were to achieve specific daily levels in total fat (⩽30%) and cholesterol (⩽300 mg). At each of the six training sessions, another selected topic regarding healthy eating (that is, junk food, beverages, fat and oil) was discussed to gain a gradual change in diet. Each training session lasted 60 mins. To assess adherence to the diet and the ingested oil, dietary records had to be conducted on 4 days (3 weekdays and 1 weekend day) and were discussed with the dietician. Psychological conversations with the subjects and their parents were held to improve motivation, compliance and quality of life.
Medical parameters and eating habits were assessed again at the end of the intervention in order to evaluate changes and the effect of the project. Furthermore, the patients and their parents were asked to complete a questionnaire on the acceptability, palatability and ease of the study oil.
Phase 3 (follow-up). Six months after the intervention period, patients were again medically examined and had to complete a 7-day nutritional protocol. In addition, they were asked about the quality of life and compliance with dietary recommendations in the recent months. The follow-up period was used to verify the sustainability of the study.
Blood collection and laboratory analyses
Venous blood sampling (6 ml blood) was done after a 12-h fasting period at baseline and end point by a trained paediatrician. A complete lipid status consisting of TC, LDL, high-density lipoprotein (HDL), apolipoprotein A1 (apoA1), apoB and lipoprotein(a) was conducted in our centralized laboratory. Lipoprotein(a) levels above 30 mg/dl were considered as pathological. 27 High-sensitivity C-reactive protein (hs-CRP) was measured by an immunological turbidity test with the test kit Dimension Clinical chemistry system (Siemens, Washington, DC, USA).
Furthermore, fatty acid composition of plasma phospholipids was analyzed using gas chromatography and mass spectrometry according to M Rodriguez-Palermo et al. 28 at the beginning and at the end of phase 2. The fatty acid composition of the study oils (10 μl sample) was determined by the same method (Table 2) .
Blood samples for molecular genetic analyses were immediately frozen (−20°C) and either sent to the laboratory diagene (Reinach, Switzerland, Dr. A. Miserez) or to the Department of Clinical Genetics, Medical University of Innsbruck (Innsbruck, Austria, Prof. J. Zschocke).
Statistical analyses
Statistical evaluation was performed using the SAS statistical package (SAS Institute, Cary, NC, USA). For tests of statistical significance, t-test for normally distributed data and the Wilcoxon signed-rank test for skewed data were used. A P-value of o0.05 was considered statistically significant. Results of the diet intervention from each group were compared by analysis of variance and checked for difference.
Power calculations were performed using SAS PROC POWER (SAS Institute Inc., Cary, NC, USA). A power of 0.8 and a significance level at α = 0.05, which was Bonferroni corrected, were assumed. Therefore, the significance level was set at α = 0.00625 for each hypothesis.
RESULTS

Plasma lipid and lipoprotein status: influence of intervention
The changes in plasma levels of the respective study groups are shown in Table 3 . First it is to note that the SO group had higher Effects of diet in hypercholesterolemic children L Negele et al basic levels for TC, LDL cholesterol, apoA1 and apoB compared with the RO group. However, after intervention an equal mean decrease of 9.4% in TC levels was observed for both fat-modified diets, but was more significant for RO than SO (Po 0.005 vs Po 0.05). LDL cholesterol levels decreased about 12.7% (P o 0.005) after RO diet and 11.3% (P o0.05) after SO diet. Thus, LDL cholesterol reduction was more pronounced in the RO group with 1.4%. An insignificant decrease in HDL cholesterol levels in both groups was associated with a comparable reduction in apoA1 levels. ApoB values decreased significantly in the SO group by an average of 10.1%, whereas the decrease of 4.4% for RO reached no significance. Another difference between the two groups was observed in the change of hs-CRP: a decrease by 16.8% for RO diet was noted, whereas a decrease of 1.7% could be achieved with SO diet. But these plasma changes did not yield statistical significance because of the relatively high variation. Moreover, body weight changed about +2% (P o 0.05) in the SO group and about +4% (P40.05) in the RO group. However, BMI did not change in both groups during the intervention phase (data not shown). The average Triglycerides (TG) value seemed to increase up to the end of the intervention in both groups.
Analysis of variance showed that there is no significant difference between the mean changes of both diets.
Effect of treatment Overall, 19 out of 21 patients (approximately 90%) showed reduced LDL cholesterol level at the end of the intervention. Seven subjects (six of the RO and one of the SO group) reached a value of o 130 mg/dl, and nine subjects (four of the RO and five of the SO group) a value of o160 mg/dl of LDL cholesterol. Thus, 16 subjects fell below the criterion of drug therapy (LDL cholesterol o160 mg/dl) after intervention. The level of LDL cholesterol of three patients of the SO group remained above 200 mg/dl. Furthermore, two subjects of each group reached a TC level below 200 mg/dl. Two more subjects from each group showed no effect on lowering LDL cholesterol and TC.
Fatty acid analysis Phospholipid fatty acid composition in plasma was analyzed to evaluate the ingestion of the study oil. Data are available from five subjects of the RO group and seven subjects of the SO group. The n-6/n-3 fatty acid ratio was decreased for RO diet in three patients and was increased in four subjects of the SO group. In accordance, oleic (C18:1 n-9) to linoleic (C18:2 n-6) acid ratio increased in plasma of two people during RO diet and decreased in five people during SO diet. However, a significant change within the groups could not be proven.
Level of acceptance Twenty patients completed a questionnaire on the acceptability and palatability of the oil. The analysis of the oil return measurement showed that the subjects had engaged the oil at an average of 78 of the 91 possible days. Six patients showed an irregular intake of the oil, because of difficulties to incorporate the oil in the daily diet. Only one person found the recommended amount of oil not appropriate. Two more subjects did not like the taste of SO. However, no patient saw the daily use of the oil as a burden. Almost 95% voted for a good tolerability of the oil. Two subjects from the SO group complained of increased incidence of abdominal pain and nausea. Nearly all patients (95%) were satisfied with the effectiveness of the oil but only about 65% would continue to take the oil from the tubes in same amounts.
Follow-up Two patients did not appear for the follow-up examination. Another three patients had to start a drug therapy after the intervention and could therefore not be included in the statistical analysis. Finally, blood parameters of 16 patients could be evaluated after 6 months and are compared with the blood parameters after the intervention in Table 4 .
A value of hs-CRP (1.58 mg/dl) was excluded from the analysis, as it was proven to be an outlier. No significant and clinically relevant changes could be detected by comparison of the parameters between the two time points.
Sample size recalculation In addition, sample size estimation was performed after the study, when it was clearly documented, which variance and changes of blood parameters can be expected for this kind of study population. We calculated the number of subjects which would be required to see a significant difference for 10% actual change to maintain a given standard deviation for each parameter. The results presented in Table 5 show that a significant change of cholesterol levels can be seen with a study population of approximately 15-24 subjects. As TG and hs-CRP had a high dispersion in this study population, more participants would be needed for a significant observation. Another calculation was performed for the number of subjects, which would be needed to identify a difference of 5% of the respective parameters between the two diets. For a detection of a significant difference between the groups, 178 and 340 subjects for TC and LDL cholesterol are required, respectively. Effects of diet in hypercholesterolemic children L Negele et al
DISCUSSION
To date, this is the first study that reports a therapeutic effect of a diet rich in MUFA (RO) compared with a diet rich in PUFA (SO) in children and adolescents with FH. However, a significant difference between the two fat-modified diets could not be pointed out, whereas a greater tendency to reduce risk markers with ingestion of RO as compared with SO was observed. The present study demonstrates that by using quality vegetable oils, while reducing saturated fatty acids and the cholesterol content in diet, a significant decrease of TC and LDL cholesterol levels can be achieved within 13 weeks (Table 3) . Moreover, the study emphasizes the importance of an early fat-modified diet as an essential step of lipid-lowering therapy: with this intervention, we reached a treatment success of 76%. That means that 16 out of 21 subjects reached a LDL cholesterol level o 160 mg/dl at postintervention and thus needed no further drug therapy. As the other patients not suspected of poor compliance, we can only speculate about the reasons of non-responding to the diet. Genetic factors such as underlying mutations of the LDL receptor or apolipoprotein E genotypes 29 might be a possible cause. Widhalm et al. 30 observed in their study population six nonresponders and suspected genetic scheduling by apolipoprotein E genotypes.
The results of this trial are in line with those of one of the previous studies concerning potential beneficial effects of a fatmodified diet in RO. 31 In the present study, we could not find significant differences between the two oil-regimes, but numerous trials have documented different effects of a diet rich in MUFA compared with a diet rich in PUFA in healthy men and women. [15] [16] [17] [18] However, another study of subjects with moderate hypercholesterolaemia showed a similar lipid-lowering effect in both RO diet and SO diet. Furthermore, a significant increase in n-3 fatty acids had been found after the RO diet. 12 Comparable trials in children affected with hereditary lipid disorders are scarce.
Keys et al. 32 observed that individuals with significant higher initial cholesterol values respond more considerably on a cholesterol-lowering diet than those with lower initial cholesterol concentrations. Hence, it is to note that, at the beginning of the present study, the mean TC and LDL cholesterol concentration in the SO group were about 30-34 mg/dl higher (Table 3 ) than in the RO group, which could have resulted in a potential bias. As longterm studies with children observed strong correlations between sexual maturation and blood lipids, 33, 34 the influence of hormones on the cholesterol level cannot be ruled in the present study. Hence, even if the participants have been equally divided between the intervention groups regarding their age, the sexual maturity might be the reason for the different initial cholesterol level of the two groups. Owing to the short intervention period, no significant changes in the hormonal status, which could have influenced the study parameters, were assumed.
Introduction of the oil diets did not result in a significant change of HDL cholesterol and apoA1 levels in and between the present study groups. This is in accordance with previous observations assuming that moderate amounts of different fatty acid classes have a comparable influence on HDL cholesterol levels. 11, 15, 35 Nevertheless, HDL cholesterol concentrations seemed to be higher after the RO than after the SO diet. Pedersen et al.
17 also observed this trend for RO during a 3-week intervention with ingestion of 50 g oil/day. Furthermore, Mata et al. 36 and Carmena et al. 37 observed lower HDL cholesterol levels after a PUFA-rich diet compared with a MUFA-rich diet. It is generally assumed that the cholesterol-lowering effect of linoleic acid partly results from lowering HDL cholesterol. This hypothesis supports the observation in our study. The concentrations of HDL cholesterol in the SO group tend to be lower, whereas TC in both groups decreased in the same ratio. According to the outcome of other studies, the reduction of TC in the RO group resulted mainly from the reduction in LDL cholesterol. 15, 16 It is also worth stating that there is a trial in adults on a RO diet, which reports that the reduction in LDL cholesterol was accompanied by an elevation in HDL cholesterol of 9%. 38 Serum TG did not change markedly during the intervention, but seemed to increase. In contrast, a meta-analysis by Gardner and Kraemer 35 reported quite contrary moderate but consistently lower TG concentrations after PUFA diets. A similar effect has been found in some other previous investigations with SO, 12,15 whereas MUFA diets have been reported to lower TG levels significantly, but may be caused by a fat-modified diet because of the more favourable effects on the CVD risk profile. 19, 39 In the present study, a reason for the unaffected TG level could be caused by the initially unaccustomed daily amount of the study oil or possibly traced by an increased intake of carbohydrate while reducing saturated fat in diet.
A consideration of Hooper et al. 40 reports a little, but still potentially important reduction of cardiovascular risk, which is particularly noticeable in studies with duration over several months, obtained with the modification of dietary fat. Hence, it can be hypothesized that the beneficial effects of the diet would probably even more significantly detectable through a longer duration of the diet or a higher intake of oil. In the present study hs-CRP and the ratio of LDL/HDL cholesterol, whose concentrations were already markedly increased among our paediatric patients affected with FH, were assessed as cardiovascular risk markers. After the intervention, a trend towards a reduction of Abbreviations: HDL, high-density lipoprotein; hs-CRP, high-sensitive C-reactive protein; LDL, low-density lipoprotein; N Total = necessary number of observations within or between the groups. a Mean change is equivalent to 10% of the actual change, α = 0.00625, power = 0.8.
b Mean change is equivalent to 5% of the actual change, α = 0.00625, power = 0.8. 15, 17, 38 whereas some others could show no difference between the two oils. 12, 16 The observed change in the fatty acid composition in plasma for approximately half of the investigated samples was in accordance with the composition of the fat-modified diets: an increase in oleic/linoleic acid ratio resulted from the RO diet and a decrease in SO diet, whereas n-6/n-3 fatty acid ratio changed contrary during the two diets. A significant change within the diet groups could not be proven. Thus, the results of fatty acids analysis alone did not provide enough information to prove compliance to the diet. However, just few studies examined the relationship of fatty acid composition and compliance in a representative free-living population. 42 Summing up the results of the fatty acid analysis in addition to measurement of the returned study oil and the evaluated dietary records, these data are sufficiently significant to be in favour of the intake of the specific oil.
A special attention within the study design was placed on the sustainability of the nutrition courses and use of the oil, because a proper diet is the basis for the treatment of FH and the prevention of premature CVD. Furthermore, the compliance of a change in diet in adolescents is more effective when it starts in childhood and may also affect positively into adulthood. 43 The eating habits with the use of the oils learned during the intervention were put to the test in the period up to the follow-up, whereas dietary training and oil were no longer provided. The results of the follow-up investigation showed no clinically relevant change in blood parameters and BMI compared with postintervention. This suggests that the dietary recommendations could be continuously maintained and thus a positive and sustainable change in dietary habits has occurred. Nevertheless, regular follow-up appointments are necessary in order to keep a proper diet in the future.
Evaluation of dietary protocols and the questionnaire revealed high levels of acceptance of the diet. Both study oils proved to be practicable, because of their neutral flavour and broad scope of application in food and drinks. Importantly, in order to achieve high compliance, it is necessary to involve the family in dietary instructions and therapy. Furthermore, diet has to be monitored closely by the dietician in cooperation with a multi-professional team of paediatrician, following a family approach.
Based on the positive results and the absence of adverse effects, we suggest that a fat-and cholesterol-restricted diet that is combined with RO or SO are a safe and potentially effective treatment regimen in paediatric age. With these results, we provide limited evidence for current guidelines in managing FH in children and young adults. 44 Furthermore, the results of the study suggest that a RO diet seemed to have more favourable effects in regard to blood lipoprotein subfractions and risk markers compared with SO diet. Although the results presented are promising, trials with a larger number of participants (see results of sample size calculation in Table 5 ) will be required to validate our findings.
